(FPRX) |
| 0 (0%) 06-03 15:44 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 228.71 |
| Resistance 1: | 195.81 |
| Pivot price: | 189.64 |
| Support 1: | 183.58 |
| Support 2: | 176.02 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 10 Jan 2023
Lori Lyons Williams Net Worth (2026) - GuruFocus
Wed, 09 Nov 2022
Aron Marc Knickerbocker Net Worth (2026) - GuruFocus
Thu, 04 Mar 2021
Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash - PR Newswire
Tue, 01 Dec 2020
Five Prime Therapeutics Stock Price Forecast. Should You Buy FPRX? - StockInvest.us
Thu, 12 Nov 2020
Five Prime Announces Pricing of Upsized Public Offering of Common Stock - Business Wire
Wed, 11 Nov 2020
Five Prime Therapeutics (FPRX) Stock Soars over 300% After Cancer Drug Update - AskTraders
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
